IL6 and cancer: STAT3 is activated by IL-6-induced dimerization of the IL-6 receptor, which leads to cancer progression in an inflammatory environment.47 Dysregulation of the IL-6-mediated JAK/STAT3 signaling pathway is link to development of several human solid tumors.13,22,44,48